Tokyo Tape
Sign in
← J Frontier

Quarterly report · Q2

2934.TEDINET S100PYFW
Period2022-06-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥9.1bn2022-06-01 → 2022-11-30Cons.Net sales
Revenue¥11.9bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2021-06-01 → 2021-11-30Cons.Net sales
Operating income−¥368m2022-06-01 → 2022-11-30Cons.Operating income
Operating income¥264m2021-06-01 → 2021-11-30Cons.Operating income
Ordinary income−¥382m2022-06-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥713m2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥238m2021-06-01 → 2021-11-30Cons.Ordinary income
Profit before tax−¥382m2022-06-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥238m2021-06-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)−¥349m2022-06-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥401m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥156m2021-06-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income−¥308m2022-06-01 → 2022-11-30Cons.Profit loss
Net income¥156m2021-06-01 → 2021-11-30Cons.Profit loss
Total assets¥7.8bnat 2022-11-30Cons.Assets
Total assets¥6.1bnat 2022-05-31Cons.Assets
Total assets¥5.5bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥3.6bnat 2022-11-30Cons.Liabilities
Total liabilities¥1.9bnat 2022-05-31Cons.Liabilities
Net assets / equity¥4.2bnat 2022-11-30Cons.Net assets
Net assets / equity¥4.2bnat 2022-05-31Cons.Net assets
Net assets / equity¥4.3bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-05-31Cons.Cash and deposits
Cash & equivalents¥2.8bnat 2022-11-30Cons.Cash and cash equivalents
Cash & equivalents¥3.0bnat 2022-05-31Cons.Cash and cash equivalents
Cash & equivalents¥4.1bnat 2021-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.6bnat 2021-05-31dCons.Cash and cash equivalents
Operating cash flow−¥594m2022-06-01 → 2022-11-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥367m2021-06-01 → 2022-05-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥288m2021-06-01 → 2021-11-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥800m2022-06-01 → 2022-11-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥860m2021-06-01 → 2022-05-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥77m2021-06-01 → 2021-11-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.3bn2022-06-01 → 2022-11-30Cons.Net cash provided by used in financing activities
Financing cash flow¥2.6bn2021-06-01 → 2022-05-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥2.8bn2021-06-01 → 2021-11-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-76.452022-06-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-47.822022-09-01 → 2022-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥90.642021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥36.312021-06-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥19.012021-09-01 → 2021-11-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥86.682021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥34.332021-06-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio50.9%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.9%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 31
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2022-11-30−¥84m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2022-11-30−¥277m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥3.0bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.9bn
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥84m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥55m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥2.0bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥266m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥4.2bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue intersegment2022-06-01 → 2022-11-30¥181,000
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥412m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥9.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥9.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-06-01 → 2022-11-30¥84m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30−¥91m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2021-11-30−¥195m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥552m
jpcrp040300-q2r_E33800-000Healthcare Marketing Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥64m
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.9bn
jpcrp040300-q2r_E33800-000Healthcare Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥391m
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentrevenue external2021-06-01 → 2021-11-30¥1.4bn
jpcrp040300-q2r_E33800-000Medical Care Sales Businessreportable segmentsegment profit2021-06-01 → 2021-11-30¥5m
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2021-11-30¥3.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2021-11-30¥459m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 489
ItemContextValueUnit
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember390518000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember63569000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember458935000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-195416000JPY
Operating incomePrior1YTDDuration263518000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember4169711000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember2019833000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember2914363000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember9103908000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration9103908000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember181000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember84222000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember84404000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-84404000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember4169893000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember2019833000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember2998586000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember9188313000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-84404000JPY
Net salesCurrentYTDDuration9103908000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E33800-000MedicalCareSalesBusinessReportableSegmentMember-412181000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareSalesBusinessReportableSegmentMember266229000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E33800-000HealthcareMarketingBusinessReportableSegmentMember54514000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember-91437000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-276542000JPY
Operating incomeCurrentYTDDuration-367980000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-01-13
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第15期第２四半期(自　2022年９月１日　至　2022年11月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)ジェイフロンティア株式会社
Company name in english cover pageFilingDateInstantJ Frontier Co.,Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長執行役員　中村　篤弘
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都渋谷区渋谷二丁目９番９号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03-6427-4662（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役執行役員グループ経営管理本部長　小田部　真司
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都渋谷区渋谷二丁目９番９号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03-6427-4662（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役執行役員グループ経営管理本部長　小田部　真司
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE33800
Fund codeFilingDateInstant－
Security codeFilingDateInstant29340
Filer name in japaneseFilingDateInstant
Original text (Japanese)ジェイフロンティア株式会社
Filer name in englishFilingDateInstantJ Frontier Co.,Ltd.
Fund name in japaneseFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-05-31pass rounding
balance sheet identityconsolidated 2022-11-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flowconsolidated 2021-06-01/2021-11-30pass
statement vs summary · operating cash flowconsolidated 2022-06-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-06-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-06-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass